Veravas, Inc., an emerging diagnostic company, is showcasing for the first time, a newly launched portfolio of laboratory products to detect and manage biotin interference at the American Association for Clinical Chemistry annual meeting on August 4-8, 2019 in Anaheim, California.
July 18, 2019
· 2 min read